(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of BCL2A1 mRNA CTD PMID:17971868 (-)-demecolcine increases expression ISO BCL2A1 (Homo sapiens) 6480464 Demecolcine results in increased expression of BCL2A1 mRNA CTD PMID:23649840 (S)-naringenin increases expression ISO BCL2A1 (Homo sapiens) 6480464 naringenin metabolite results in increased expression of BCL2A1 mRNA CTD PMID:36235125 (S)-naringenin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA CTD PMID:36235125 (S)-nicotine decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of BCL2A1 mRNA CTD PMID:18247414 1'-acetoxychavicol acetate multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15905586 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT results in increased expression of BCL2A1 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o and p'-DDT analog results in decreased expression of BCL2A1 mRNA CTD PMID:22937105 1,2-dimethylhydrazine increases expression ISO Bcl2a1b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of BCL2A1B mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO BCL2A1 (Homo sapiens) 6480464 1-nitropyrene results in increased expression of BCL2A1 mRNA CTD PMID:21540303 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2A1 mRNA CTD PMID:19520675 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bcl2a1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2A1B mRNA CTD PMID:21041162 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Bcl2a1b (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BCL2A1B mRNA CTD PMID:17982090 2-hydroxypropanoic acid decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of BCL2A1 mRNA CTD PMID:30851411 2-naphthylamine increases expression ISO BCL2A1 (Homo sapiens) 6480464 2-Naphthylamine results in increased expression of BCL2A1 mRNA CTD PMID:18247414 3,3',5-triiodo-L-thyronine multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Triiodothyronine promotes the reaction [tamibarotene results in increased expression of BCL2A1A mRNA] CTD PMID:11201846 4-hydroxynon-2-enal decreases expression ISO Bcl2a1b (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of BCL2A1B mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Fenretinide results in decreased expression of BCL2A1 protein CTD PMID:16230421 4-hydroxyphenyl retinamide increases expression ISO Bcl2a1b (Mus musculus) 6480464 Fenretinide results in increased expression of BCL2A1 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide increases expression ISO Bcl2a1b (Mus musculus) 6480464 4-Nitroquinoline-1-oxide results in increased expression of BCL2A1B mRNA CTD PMID:22561872 6alpha-methylprednisolone decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Methylprednisolone results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 acetamide increases expression EXP 6480464 acetamide results in increased expression of BCL2A1 mRNA CTD PMID:31881176 actinomycin D multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 BCL2A1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] CTD PMID:11880364 aflatoxin B1 increases expression ISO BCL2A1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of BCL2A1 mRNA CTD PMID:21641981 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BCL2A1 mRNA CTD PMID:25378103 aflatoxin B1 increases methylation ISO BCL2A1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of BCL2A1 gene CTD PMID:27153756 all-trans-retinoic acid multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA more ... CTD PMID:11133770 more ... all-trans-retinoic acid increases expression ISO BCL2A1 (Homo sapiens) 6480464 Tretinoin results in increased expression of BCL2A1 mRNA and Tretinoin results in increased expression of BCL2A1A protein CTD PMID:10673743 more ... antirheumatic drug decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of BCL2A1 mRNA CTD PMID:17696278 and PMID:24449571 antirheumatic drug multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 BCL2A1 mRNA results in decreased susceptibility to [Methotrexate co-treated with Antirheumatic Agents] CTD PMID:22753658 aristolochic acid A increases expression ISO BCL2A1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of BCL2A1 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO Bcl2a1b (Mus musculus) 6480464 arsenite results in decreased expression of BCL2A1B mRNA CTD PMID:18191166 arsenous acid decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BCL2A1 mRNA CTD PMID:19128835 arsenous acid increases expression ISO BCL2A1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2A1 mRNA CTD PMID:10673743 and PMID:17530438 arsenous acid multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA more ... CTD PMID:11133770 more ... azathioprine decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 bathocuproine disulfonic acid multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] and bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA]] CTD PMID:15477007 benzene increases expression ISO BCL2A1 (Homo sapiens) 6480464 Benzene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of BCL2A1 mRNA CTD PMID:18247414 benzo[a]pyrene increases methylation ISO BCL2A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of BCL2A1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO BCL2A1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of BCL2A1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Bcl2a1b (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BCL2A1B mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO BCL2A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BCL2A1 mRNA CTD PMID:20106945 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL2A1 mRNA CTD PMID:18180321 and PMID:32145629 bisphenol A increases expression ISO Bcl2a1b (Mus musculus) 6480464 bisphenol A results in increased expression of BCL2A1B mRNA CTD PMID:38074096 bisphenol A multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA CTD PMID:36235125 bisphenol A increases expression ISO BCL2A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of BCL2A1 mRNA CTD PMID:33312107 bisphenol A decreases expression ISO Bcl2a1b (Mus musculus) 6480464 bisphenol A results in decreased expression of BCL2A1B mRNA CTD PMID:25594700 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL2A1 mRNA CTD PMID:25181051 bortezomib increases expression ISO BCL2A1 (Homo sapiens) 6480464 Bortezomib results in increased expression of BCL2A1A protein CTD PMID:20051518 bortezomib multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BCL2A1 protein CTD PMID:18223231 butanal increases expression ISO BCL2A1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of BCL2A1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of BCL2A1 mRNA and Cadmium Chloride results in decreased expression of BCL2A1 protein CTD PMID:12160620 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCL2A1 mRNA CTD PMID:25993096 calcitriol increases expression ISO BCL2A1 (Homo sapiens) 6480464 Calcitriol results in increased expression of BCL2A1 mRNA CTD PMID:15951637 and PMID:16847355 cannabidiol multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in increased expression of BCL2A1 mRNA CTD PMID:30096889 carbon monoxide multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]] and MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] CTD PMID:11880364 carbon nanotube increases expression ISO BCL2A1 (Homo sapiens) 6480464 Nanotubes and Carbon analog results in increased expression of BCL2A1 mRNA CTD PMID:25102311 CGP 52608 multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to BCL2A1 gene] CTD PMID:28238834 cholesterol increases expression EXP 6480464 Cholesterol analog results in increased expression of BCL2A1 mRNA CTD PMID:19477266 choline multiple interactions ISO Bcl2a1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2A1B mRNA CTD PMID:20938992 chromium(6+) affects expression ISO Bcl2a1b (Mus musculus) 6480464 chromium hexavalent ion affects the expression of BCL2A1B mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO Bcl2a1b (Mus musculus) 6480464 Ciguatoxins affects the expression of BCL2A1B mRNA CTD PMID:18353800 cisplatin increases expression ISO BCL2A1 (Homo sapiens) 6480464 Cisplatin results in increased expression of BCL2A1 mRNA CTD PMID:19561079 more ... copper atom multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of BCL2A1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of BCL2A1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO BCL2A1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of BCL2A1 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO BCL2A1 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of BCL2A1 mRNA CTD PMID:25351596 CU-O LINKAGE decreases expression ISO BCL2A1 (Homo sapiens) 6480464 cupric oxide results in decreased expression of BCL2A1 mRNA CTD PMID:22077320 curcumin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2A1 mRNA] CTD PMID:16219905 curcumin decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Curcumin results in decreased expression of BCL2A1 mRNA CTD PMID:17596214 dexamethasone increases expression ISO Bcl2a1b (Mus musculus) 6480464 Dexamethasone results in increased expression of BCL2A1B mRNA CTD PMID:21041162 diarsenic trioxide increases expression ISO BCL2A1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2A1 mRNA CTD PMID:10673743 and PMID:17530438 diarsenic trioxide multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA more ... CTD PMID:11133770 more ... diarsenic trioxide decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BCL2A1 mRNA CTD PMID:19128835 dichloromethane increases expression ISO BCL2A1 (Homo sapiens) 6480464 Methylene Chloride results in increased expression of BCL2A1 mRNA CTD PMID:20359517 diclofenac decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Diclofenac results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of BCL2A1 mRNA CTD PMID:21161181 diosgenin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:16331273 diosgenin decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Diosgenin results in decreased expression of BCL2A1 protein CTD PMID:16331273 dioxygen decreases expression ISO Bcl2a1b (Mus musculus) 6480464 Oxygen deficiency results in decreased expression of BCL2A1B mRNA CTD PMID:24205000 doxorubicin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Tretinoin results in increased expression of BCL2A1 mRNA] which results in decreased susceptibility to Doxorubicin CTD PMID:16572199 doxorubicin decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BCL2A1 mRNA CTD PMID:29803840 doxorubicin affects response to substance ISO BCL2A1 (Homo sapiens) 6480464 BCL2A1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCL2A1 mRNA CTD PMID:29391264 eriodictyol multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 eriodictyol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 ethyl methanesulfonate decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of BCL2A1 mRNA CTD PMID:23649840 ethylbenzene increases expression ISO BCL2A1 (Homo sapiens) 6480464 ethylbenzene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 Evodiamine multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15710601 fenofibrate decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Fenofibrate results in decreased expression of BCL2A1 mRNA CTD PMID:20520642 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of BCL2A1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO Bcl2a1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2A1B mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of BCL2A1 mRNA CTD PMID:22079235 Fusarenone X increases expression ISO Bcl2a1b (Mus musculus) 6480464 fusarenon-X results in increased expression of BCL2A1B mRNA CTD PMID:24983900 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCL2A1 mRNA CTD PMID:22061828 glycochenodeoxycholic acid increases expression EXP 6480464 Glycochenodeoxycholic Acid results in increased expression of BCL2A1 mRNA CTD PMID:15767249 glyphosate increases expression ISO BCL2A1 (Homo sapiens) 6480464 Glyphosate results in increased expression of BCL2A1 mRNA CTD PMID:31874349 guggulsterone multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 pregna-4 more ... CTD PMID:15322087 imidazopyrazole increases expression ISO BCL2A1 (Homo sapiens) 6480464 imidazopyrazole analog results in increased expression of BCL2A1 mRNA CTD PMID:30388846 indole-3-methanol multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15811958 indometacin decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Indomethacin results in decreased expression of BCL2A1 mRNA and Indomethacin results in decreased expression of BCL2A1 protein CTD PMID:17054584 ionomycin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] more ... CTD PMID:15477007 iron(2+) sulfate (anhydrous) increases expression ISO BCL2A1 (Homo sapiens) 6480464 ferrous sulfate results in increased expression of BCL2A1 mRNA CTD PMID:21540303 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of BCL2A1 mRNA CTD PMID:16978161 kaempferol multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 kaempferol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 kojic acid increases expression ISO BCL2A1 (Homo sapiens) 6480464 kojic acid results in increased expression of BCL2A1 mRNA CTD PMID:16595896 L-methionine multiple interactions ISO Bcl2a1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2A1B mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO Bcl2a1b (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of BCL2A1B mRNA CTD PMID:25890327 lipopolysaccharide multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BCL2A1 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO BCL2A1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of BCL2A1 mRNA CTD PMID:15860229 more ... lonafarnib multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15090542 LY294002 multiple interactions ISO Bcl2a1b (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased expression of BCL2A1 mRNA] CTD PMID:16256798 maneb increases expression ISO BCL2A1 (Homo sapiens) 6480464 Maneb results in increased expression of BCL2A1 mRNA CTD PMID:18266926 maneb multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2A1 protein CTD PMID:18266926 melphalan increases expression ISO BCL2A1 (Homo sapiens) 6480464 Melphalan results in increased expression of BCL2A1 mRNA CTD PMID:22363485 methotrexate decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Methotrexate results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 methotrexate increases expression ISO BCL2A1 (Homo sapiens) 6480464 Methotrexate results in increased expression of BCL2A1 mRNA CTD PMID:17696278 and PMID:25575725 methotrexate decreases response to substance ISO BCL2A1 (Homo sapiens) 6480464 BCL2A1 mRNA results in decreased susceptibility to Methotrexate CTD PMID:22753658 methotrexate multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 BCL2A1 mRNA results in decreased susceptibility to [Methotrexate co-treated with Antirheumatic Agents] CTD PMID:22753658 methyl methanesulfonate decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of BCL2A1 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO BCL2A1 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of BCL2A1 mRNA CTD PMID:31629900 methylseleninic acid increases expression ISO BCL2A1 (Homo sapiens) 6480464 methylselenic acid results in increased expression of BCL2A1 mRNA CTD PMID:11830524 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of BCL2A1 mRNA CTD PMID:23485034 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of BCL2A1 mRNA CTD PMID:21515302 N-(6-acetamidohexyl)acetamide multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA and [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA CTD PMID:12130515 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of BCL2A1 protein CTD PMID:17337753 nickel atom multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of BCL2A1A mRNA] CTD PMID:14575637 nickel atom increases expression ISO BCL2A1 (Homo sapiens) 6480464 Nickel results in increased expression of BCL2A1 mRNA CTD PMID:24768652 and PMID:25583101 nickel atom affects expression ISO BCL2A1 (Homo sapiens) 6480464 Nickel affects the expression of BCL2A1A mRNA CTD PMID:14575637 nickel dichloride increases expression ISO BCL2A1 (Homo sapiens) 6480464 nickel chloride results in increased expression of BCL2A1 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO BCL2A1 (Homo sapiens) 6480464 nickel sulfate results in increased expression of BCL2A1 mRNA CTD PMID:16780908 nicotine decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of BCL2A1 mRNA CTD PMID:18247414 o-xylene increases expression ISO BCL2A1 (Homo sapiens) 6480464 2-xylene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BCL2A1 mRNA CTD PMID:19562491 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of BCL2A1 mRNA CTD PMID:23439660 ozone increases expression ISO BCL2A1 (Homo sapiens) 6480464 Ozone results in increased expression of BCL2A1 mRNA CTD PMID:23033980 ozone decreases expression ISO Bcl2a1b (Mus musculus) 6480464 Ozone results in decreased expression of BCL2A1B mRNA CTD PMID:33026818 paracetamol affects expression ISO Bcl2a1b (Mus musculus) 6480464 Acetaminophen affects the expression of BCL2A1B mRNA CTD PMID:17562736 paraquat decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Paraquat results in decreased expression of BCL2A1 mRNA CTD PMID:18836921 paraquat multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2A1 protein CTD PMID:18266926 paraquat increases expression ISO BCL2A1 (Homo sapiens) 6480464 Paraquat results in increased expression of BCL2A1 mRNA and Paraquat results in increased expression of BCL2A1 protein CTD PMID:18056701 and PMID:18266926 pentanal increases expression ISO BCL2A1 (Homo sapiens) 6480464 pentanal results in increased expression of BCL2A1 mRNA CTD PMID:26079696 peptidoglycan increases expression ISO BCL2A1 (Homo sapiens) 6480464 Peptidoglycan results in increased expression of BCL2A1 mRNA CTD PMID:15860229 phorbol 13-acetate 12-myristate multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 5 more ... CTD PMID:15477007 more ... phorbol 13-acetate 12-myristate increases expression ISO BCL2A1 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA CTD PMID:20438634 pirinixic acid increases expression ISO Bcl2a1b (Mus musculus) 6480464 pirinixic acid results in increased expression of BCL2A1B mRNA CTD PMID:23811191 piroxicam decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Piroxicam results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in increased expression of BCL2A1 mRNA CTD PMID:26923065 prednisolone decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Prednisolone results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 pregnenolone 16alpha-carbonitrile decreases expression ISO Bcl2a1b (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of BCL2A1B mRNA CTD PMID:22698814 propanal increases expression ISO BCL2A1 (Homo sapiens) 6480464 propionaldehyde results in increased expression of BCL2A1 mRNA CTD PMID:26079696 protein kinase inhibitor multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2A1 mRNA] CTD PMID:28003376 pyridaben increases expression ISO Bcl2a1b (Mus musculus) 6480464 pyridaben results in increased expression of BCL2A1 mRNA CTD PMID:22563483 pyrrolidine dithiocarbamate multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] more ... CTD PMID:15477007 quercetin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 rac-lactic acid decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of BCL2A1 mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of BCL2A1 protein CTD PMID:27634759 resveratrol decreases expression ISO BCL2A1 (Homo sapiens) 6480464 resveratrol results in decreased expression of BCL2A1 protein CTD PMID:17164350 resveratrol increases expression ISO BCL2A1 (Homo sapiens) 6480464 resveratrol results in increased expression of BCL2A1 mRNA CTD PMID:25888808 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of BCL2A1 mRNA CTD PMID:25905778 romidepsin multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BCL2A1 protein CTD PMID:18223231 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO BCL2A1 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of BCL2A1 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BCL2A1 mRNA CTD PMID:35811015 silicon dioxide increases expression ISO BCL2A1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of BCL2A1 mRNA and Silicon Dioxide results in increased expression of BCL2A1 mRNA CTD PMID:21540303 more ... silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of BCL2A1 mRNA CTD PMID:22431001 simazine decreases expression ISO Bcl2a1b (Mus musculus) 6480464 Simazine results in decreased expression of BCL2A1 mRNA CTD PMID:25461544 sodium arsenite increases expression ISO BCL2A1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of BCL2A1 mRNA CTD PMID:12016162 and PMID:29049844 sodium aurothiomalate decreases expression ISO BCL2A1 (Homo sapiens) 6480464 Gold Sodium Thiomalate results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of BCL2A1 mRNA CTD PMID:25993096 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of BCL2A1 mRNA CTD PMID:25905778 sulforaphane increases expression ISO BCL2A1 (Homo sapiens) 6480464 sulforaphane results in increased expression of BCL2A1 mRNA CTD PMID:26833863 tamibarotene multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 Triiodothyronine promotes the reaction [tamibarotene results in increased expression of BCL2A1A mRNA] CTD PMID:11201846 tamibarotene increases expression ISO BCL2A1 (Homo sapiens) 6480464 tamibarotene results in increased expression of BCL2A1 mRNA and tamibarotene results in increased expression of BCL2A1A mRNA CTD PMID:11201846 and PMID:15498508 tetrachloromethane multiple interactions ISO Bcl2a1b (Mus musculus) 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2A1B mRNA] CTD PMID:18038451 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BCL2A1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Bcl2a1b (Mus musculus) 6480464 titanium dioxide results in increased expression of BCL2A1B mRNA CTD PMID:23131501 more ... toluene increases expression ISO BCL2A1 (Homo sapiens) 6480464 Toluene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 and PMID:28245982 topotecan increases expression EXP 6480464 Topotecan results in increased expression of BCL2A1 mRNA CTD PMID:25729387 Tributyltin oxide increases expression ISO BCL2A1 (Homo sapiens) 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL2A1 mRNA CTD PMID:24247028 trichloroethene increases expression ISO BCL2A1 (Homo sapiens) 6480464 Trichloroethylene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BCL2A1 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of BCL2A1A mRNA] CTD PMID:14575637 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of BCL2A1 mRNA CTD PMID:30589522 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of BCL2A1 mRNA CTD PMID:21515302 undecane increases expression EXP 6480464 undecane results in increased expression of BCL2A1 protein CTD PMID:17337753 vincristine increases expression ISO BCL2A1 (Homo sapiens) 6480464 Vincristine results in increased expression of BCL2A1 mRNA CTD PMID:23649840 vorinostat decreases expression ISO BCL2A1 (Homo sapiens) 6480464 vorinostat results in decreased expression of BCL2A1 protein CTD PMID:15897598 withaferin A multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 zerumbone decreases expression ISO BCL2A1 (Homo sapiens) 6480464 zerumbone results in decreased expression of BCL2A1 mRNA CTD PMID:16007145 zinc atom multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA CTD PMID:16979875 zinc dichloride increases expression ISO BCL2A1 (Homo sapiens) 6480464 zinc chloride results in increased expression of BCL2A1 mRNA CTD PMID:21540303 zinc(0) multiple interactions ISO BCL2A1 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA CTD PMID:16979875 zoledronic acid decreases expression ISO BCL2A1 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of BCL2A1 mRNA CTD PMID:19036117